MedTrace Logo

Survey Study - Sensitivity Comparison Between MelaFind and Physician Group

NCT01011153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2012-02-14

Study results available
· View outcomes & findings →

Summary

This survey study purposes to determine and compare the biopsy/referral sensitivity and specificity of MelaFind to the average biopsy/referral sensitivity and specificity of dermatologists. 241 subjects logged into system but only 183 signed consents and completed the intake survey. Out of these 183, 155 were accounted for in the data analysis after exclusions were removed from the pool of subjects.

Conditions

Sponsors & Collaborators

  • MELA Sciences, Inc.

    lead INDUSTRY

Principal Investigators

  • Suephy Chen, MD · Emory University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-02-28
Completion
2010-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01011153 on ClinicalTrials.gov